News
14h
Pharmaceutical Technology on MSNFDA approves label expansion of AbbVie hepatitis C therapyThe US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for ...
The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...
ASPPH proudly joined public health and medical leaders for a Congressional Briefing on the Hepatitis C Elimination Imperative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results